Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer ; volume:10 ; number:1 ; day:12 ; month:5 ; year:2017 ; pages:1-5 ; date:12.2017
Journal of hematology & oncology ; 10, Heft 1 (12.5.2017), 1-5, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Singh, Prabhsimranjot
- Beteiligte Personen und Organisationen
-
Toom, Sudhamshi
Huang, Yiwu
SpringerLink (Online service)
- DOI
-
10.1186/s13045-017-0473-4
- URN
-
urn:nbn:de:1111-20170522792
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Singh, Prabhsimranjot
- Toom, Sudhamshi
- Huang, Yiwu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer